The story of Viagra, originally marketed by copyright, presents a fascinating case study for backers considering the pharmaceutical arena . Despite its groundbreaking success and impact of billions in earnings , the patent lapse has opened the way for competing medications, greatly eroding income opportunities. This shift raises questions about the